SARS-CoV2 Testing in Long Term Care Centers

Nursing Home populations are at high risk for infection and seri- ous illness including death from COVID-19. The only approved test for identification of those in the acute phase of infection is the reverse transcription-polymerase chain reaction (rt-PCR).

Key Highlights of LongTerm Care SARSCoV2 Program

• Facility wide testing of all residents should be considered in facilities with suspected or confirmed cases of SARS-CoV2. Testing should be used to lead to specific infection prevention and control interventions (IPC)

• Separation of those with SARS-CoV-2 infection from those without detectable infection
• Testing of healthcare providers should be considered in facilities with suspected or confirmed cases of

• Identification of healthcare providers with SARS-CoV2 infection for work exclusion

Repeat Testing Considerations

  • Retest any resident that develops symptoms consistent with SARS-CoV2
  • Retest residents that frequently leave the facility for dialysis or other services that are known to ex- pose residents to those with possible infection
  • Retest healthcare providers who develop symptoms consistent with SARS-CoV2
  • Consider retesting healthcare providers at a predetermined frequency if community prevalence of infections is high.

Centers for Disease Control Guidelines Published April 30, 2020

Share This Post

More To Explore

Testing Info

SARS-CoV2 Ba.5

Much of the US is experiencing a sustained resurgence of the SARS-CoV2 virus that has lasted for the last 6 weeks and is showing no

Testing Info

Molecular Diagnosis of Wound Infections

Problem Chronic, non-healing wounds such as diabetic foot ulcers and venous stasis ulcers are often infected with a polymicrobial biofilm Traditional microbiology culture fails to